These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 20348395)
1. Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Zhu D; Wang Y; Singh I; Bell RD; Deane R; Zhong Z; Sagare A; Winkler EA; Zlokovic BV Blood; 2010 Jun; 115(23):4963-72. PubMed ID: 20348395 [TBL] [Abstract][Full Text] [Related]
2. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region. Zhong Z; Wang Y; Guo H; Sagare A; Fernández JA; Bell RD; Barrett TM; Griffin JH; Freeman RS; Zlokovic BV J Neurosci; 2010 Nov; 30(46):15521-34. PubMed ID: 21084607 [TBL] [Abstract][Full Text] [Related]
3. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G Elife; 2014 Sep; 3():. PubMed ID: 25265470 [TBL] [Abstract][Full Text] [Related]
4. The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner. Fraineau S; Monvoisin A; Clarhaut J; Talbot J; Simonneau C; Kanthou C; Kanse SM; Philippe M; Benzakour O Blood; 2012 Dec; 120(25):5073-83. PubMed ID: 23065156 [TBL] [Abstract][Full Text] [Related]
5. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation. Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926 [TBL] [Abstract][Full Text] [Related]
6. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324 [TBL] [Abstract][Full Text] [Related]
7. High incidence of distal vaginal atresia in mice lacking Tyro3 RTK subfamily. Wu H; Tang H; Chen Y; Wang H; Han D Mol Reprod Dev; 2008 Dec; 75(12):1775-82. PubMed ID: 18393392 [TBL] [Abstract][Full Text] [Related]
8. Protein S Protects against Podocyte Injury in Diabetic Nephropathy. Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111 [No Abstract] [Full Text] [Related]
9. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells. Al Kafri N; Hafizi S Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510 [TBL] [Abstract][Full Text] [Related]
10. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Singleton PA; Chatchavalvanich S; Fu P; Xing J; Birukova AA; Fortune JA; Klibanov AM; Garcia JG; Birukov KG Circ Res; 2009 Apr; 104(8):978-86. PubMed ID: 19286607 [TBL] [Abstract][Full Text] [Related]
11. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells. Brown JE; Krodel M; Pazos M; Lai C; Prieto AL PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290 [TBL] [Abstract][Full Text] [Related]
12. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation. Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554 [TBL] [Abstract][Full Text] [Related]
13. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer. Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820 [TBL] [Abstract][Full Text] [Related]
14. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. Finigan JH; Dudek SM; Singleton PA; Chiang ET; Jacobson JR; Camp SM; Ye SQ; Garcia JG J Biol Chem; 2005 Apr; 280(17):17286-93. PubMed ID: 15710622 [TBL] [Abstract][Full Text] [Related]
15. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells. Park HJ; Baen JY; Lee YJ; Choi YH; Kang JL Mol Biol Cell; 2012 Aug; 23(16):3254-65. PubMed ID: 22740630 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis. van den Brand BT; Abdollahi-Roodsaz S; Vermeij EA; Bennink MB; Arntz OJ; Rothlin CV; van den Berg WB; van de Loo FA Arthritis Rheum; 2013 Mar; 65(3):671-80. PubMed ID: 23203851 [TBL] [Abstract][Full Text] [Related]
18. The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. Miner JJ; Daniels BP; Shrestha B; Proenca-Modena JL; Lew ED; Lazear HM; Gorman MJ; Lemke G; Klein RS; Diamond MS Nat Med; 2015 Dec; 21(12):1464-72. PubMed ID: 26523970 [TBL] [Abstract][Full Text] [Related]
19. Systemic autoimmunity in TAM triple knockout mice causes inflammatory brain damage and cell death. Li Q; Lu Q; Lu H; Tian S; Lu Q PLoS One; 2013; 8(6):e64812. PubMed ID: 23840307 [TBL] [Abstract][Full Text] [Related]
20. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement. Adyshev DM; Moldobaeva NK; Elangovan VR; Garcia JG; Dudek SM Cell Signal; 2011 Dec; 23(12):2086-96. PubMed ID: 21864676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]